Clinical Effect of CD25 on the Prognosis of Diffuse Large B Cell Lymphoma with Secondary Central Nervous System Relapse

In the present study, we investigated the effects of immunophenotyping on prognosis of diffuse large B cell lymphoma (DLBCL) with central nervous system (CNS) relapse treated with rituximab-CHOP (R-CHOP). CNS relapse occurred in 9.5% of DLBCL patients. At the diagnosis of DLBCL, CD25 was detected in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pathology oncology research 2020-07, Vol.26 (3), p.1843-1850
Hauptverfasser:	Oka, Satoko, Ono, Kazuo, Nohgawa, Masaharu
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use B-cell lymphoma Biomarkers, Tumor - immunology Biomedical and Life Sciences Biomedicine Cancer Research CD25 antigen Central nervous system Central Nervous System Neoplasms - immunology Central Nervous System Neoplasms - pathology Cyclophosphamide - therapeutic use Doxorubicin - therapeutic use Female Humans Immunology Immunophenotyping Immunotherapy Interleukin-2 Receptor alpha Subunit - biosynthesis Lymphoma Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - immunology Lymphoma, Large B-Cell, Diffuse - pathology Male Medical prognosis Middle Aged Monoclonal antibodies Multivariate analysis Neoplasm Recurrence, Local - immunology Neoplasm Recurrence, Local - pathology Nervous system Oncology Original Article Pathology Patients Prednisone - therapeutic use Prognosis Retrospective Studies Rituximab Rituximab - therapeutic use Targeted cancer therapy Vincristine - therapeutic use Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!